395 related articles for article (PubMed ID: 20420867)
1. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic drug delivery system: a review.
Semalty A; Semalty M; Singh R; Saraf SK; Saraf S
Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833
[TBL] [Abstract][Full Text] [Related]
3. Skin electroporation for transdermal and topical delivery.
Denet AR; Vanbever R; Préat V
Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
5. Transdermal drug delivery.
Guy RH
Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
9. Iontophoresis: an alternative drug-delivery system.
Garrison J
Med Device Technol; 1998; 9(6):32-6. PubMed ID: 10182124
[TBL] [Abstract][Full Text] [Related]
10. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis.
Kajimoto K; Yamamoto M; Watanabe M; Kigasawa K; Kanamura K; Harashima H; Kogure K
Int J Pharm; 2011 Jan; 403(1-2):57-65. PubMed ID: 20970487
[TBL] [Abstract][Full Text] [Related]
12. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
Vemulapalli V; Yang Y; Friden PM; Banga AK
J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic drug delivery using the IOMED Phoresor system.
Fischer GA
Expert Opin Drug Deliv; 2005 Mar; 2(2):391-403. PubMed ID: 16296762
[TBL] [Abstract][Full Text] [Related]
16. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
17. Transdermal drug delivery systems: skin perturbation devices.
Brown MB; Traynor MJ; Martin GP; Akomeah FK
Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
Yan G; Li SK; Higuchi WI
J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
[TBL] [Abstract][Full Text] [Related]
19. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
20. Reversible skin permeabilization for transdermal delivery of macromolecules.
Prausnitz MR
Crit Rev Ther Drug Carrier Syst; 1997; 14(4):455-83. PubMed ID: 9450177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
